金黄色葡萄球菌菌血症的抗血小板治疗：过去的时光并非一无是处？
Antiplatelet Therapy in Staphylococcus aureus Bacteremia: No Time Like the Past?
机构信息
Department of Medicine, Division of Infectious Diseases, Duke University Medical Center, Durham, North Carolina, USA.
Duke Clinical Research Institute, Durham, North Carolina, USA.
出版信息
Antimicrob Agents Chemother. 2022 Jun 21;66(6):e0036522. doi: 10.1128/aac.00365-22. Epub 2022 May 10.
Abstract
In this invited commentary, we reflect on the accompanying study by A. R. Caffrey, H. J. Appaneal, K. L. LaPlante, V. V. Lopes, et al. (Antimicrob Agents Chemother 66:e02117-21, 2022, https://doi.org/10.1128/aac.02117-21), which analyzed the impact of clopidogrel use on clinical outcomes in Staphylococcus aureus bacteremia.
摘要
在这篇特邀评论中，我们对 A. R. Caffrey、H. J. Appaneal、K. L. LaPlante、V. V. Lopes 等人的伴随研究进行了反思（Antimicrob Agents Chemother 66:e02117-21，2022，https://doi.org/10.1128/aac.02117-21），该研究分析了氯吡格雷在金黄色葡萄球菌菌血症中的使用对临床结果的影响。
相似文献
1
Antiplatelet Therapy in Staphylococcus aureus Bacteremia: No Time Like the Past?
Antimicrob Agents Chemother. 2022 Jun 21;66(6):e0036522. doi: 10.1128/aac.00365-22. Epub 2022 May 10.
2
Ticagrelor Increases Platelet-Mediated Staphylococcus aureus Killing, Resulting in Clearance of Bacteremia.
J Infect Dis. 2021 Nov 16;224(9):1566-1569. doi: 10.1093/infdis/jiab146.
3
Antiplatelet therapy for Staphylococcus aureus bacteremia: Will it stick?
PLoS Pathog. 2022 Feb 10;18(2):e1010240. doi: 10.1371/journal.ppat.1010240. eCollection 2022 Feb.
4
Management of bacteremia in adults.
CMAJ. 2019 Sep 3;191(35):E967. doi: 10.1503/cmaj.190363.
5
[Outpatient parenteral antimicrobial therapy for Staphylococcus aureus bacteremia].
Med Clin (Barc). 2011 Nov 26;137(14):663-4. doi: 10.1016/j.medcli.2011.03.005. Epub 2011 May 4.
6
Role of high vancomycin minimum inhibitory concentration in the outcome of methicillin-susceptible Staphylococcus aureus bacteremia.
J Infect Dis. 2012 Mar 15;205(6):1024-5. doi: 10.1093/infdis/jir870. Epub 2012 Jan 18.
7
Cefazolin therapy for Staphylococcus aureus bacteremia.
Clin Infect Dis. 2005 Jul 1;41(1):127. doi: 10.1086/430833.
8
Impact of an assay that enables rapid determination of Staphylococcus species and their drug susceptibility on the treatment of patients with positive blood culture results.
Infect Control Hosp Epidemiol. 2010 Oct;31(10):1043-8. doi: 10.1086/656248.
9
Clinical Practice Variation Among Adult Infectious Disease Physicians in the Management of Staphylococcus aureus Bacteremia.
Clin Infect Dis. 2019 Jul 18;69(3):530-533. doi: 10.1093/cid/ciy1144.
10
Paradoxical relationship between the clinical outcome of Staphylococcus aureus bacteremia and the minimum inhibitory concentration of vancomycin.
Clin Infect Dis. 2009 Apr 1;48(7):997-8. doi: 10.1086/597359.
本文引用的文献
1
Impact of Clopidogrel on Clinical Outcomes in Patients with Staphylococcus aureus Bacteremia: a National Retrospective Cohort Study.
Antimicrob Agents Chemother. 2022 Jun 21;66(6):e0211721. doi: 10.1128/aac.02117-21. Epub 2022 Apr 13.
2
Ticagrelor Increases Platelet-Mediated Staphylococcus aureus Killing, Resulting in Clearance of Bacteremia.
J Infect Dis. 2021 Nov 16;224(9):1566-1569. doi: 10.1093/infdis/jiab146.
3
Risk of infectious events in acute myocardial infarction patients treated with ticagrelor or clopidogrel.
Eur J Intern Med. 2021 Mar;85:121-123. doi: 10.1016/j.ejim.2020.10.016. Epub 2020 Nov 14.
4
Clinical Outcomes Associated With the Use of Anticoagulant and Antiplatelet Agents in Patients Undergoing Treatment for Infective Endocarditis: A Pilot Study.
Clin Ther. 2020 Sep;42(9):1828-1838. doi: 10.1016/j.clinthera.2020.07.007. Epub 2020 Aug 2.
5
Ticagrelor and the risk of Staphylococcus aureus bacteraemia and other infections.
Eur Heart J Cardiovasc Pharmacother. 2022 Jan 5;8(1):13-19. doi: 10.1093/ehjcvp/pvaa099.
6
Effect of Ticagrelor on Reducing the Risk of Gram-Positive Infections in Patients With Acute Coronary Syndrome.
Am J Cardiol. 2020 Sep 1;130:56-63. doi: 10.1016/j.amjcard.2020.06.016. Epub 2020 Jun 17.
7
Comparative Efficacy and Safety of Oral P2Y Inhibitors in Acute Coronary Syndrome: Network Meta-Analysis of 52 816 Patients From 12 Randomized Trials.
Circulation. 2020 Jul 14;142(2):150-160. doi: 10.1161/CIRCULATIONAHA.120.046786. Epub 2020 May 29.
8
Antibacterial Activity of Ticagrelor in Conventional Antiplatelet Dosages Against Antibiotic-Resistant Gram-Positive Bacteria.
JAMA Cardiol. 2019 Jun 1;4(6):596-599. doi: 10.1001/jamacardio.2019.1189.
9
Vital Signs: Epidemiology and Recent Trends in Methicillin-Resistant and in Methicillin-Susceptible Staphylococcus aureus Bloodstream Infections - United States.
MMWR Morb Mortal Wkly Rep. 2019 Mar 8;68(9):214-219. doi: 10.15585/mmwr.mm6809e1.
10
Prophylaxis of experimental endocarditis with antiplatelet and antithrombin agents: a role for long-term prevention of infective endocarditis in humans?
J Infect Dis. 2015 Jan 1;211(1):72-9. doi: 10.1093/infdis/jiu426. Epub 2014 Aug 1.
Zotero 插件